Lawmakers Take Investigation into Emflaza’s Price to New Owner, PTC Therapeutics

Drug Industry Daily
A A
Sen. Bernie Sanders (I-Vt.) and Rep. Elijah Cummings (D-Md.) have not halted their investigation into the pricing of Emflaza, pursuing its sale from Marathon to PTC Therapeutics.

To View This Article:

Login

Subscribe To Drug Industry Daily